EHC - Encompass Health Corp Stock Price, Fair Value and News

82.72USD+0.26 (+0.32%)Market Closed

Market Summary

USD82.72+0.26

Market Closed

0.32%

EHC Stock Price

View Fullscreen

EHC RSI Chart

EHC Valuation

Market Cap

8.3B

Price/Earnings (Trailing)

23.46

Price/Sales (Trailing)

1.72

EV/EBITDA

10.62

Price/Free Cashflow

9.71

EHC Price/Sales (Trailing)

EHC Profitability

EBT Margin

12.65%

Return on Equity

21.37%

Return on Assets

5.77%

Free Cashflow Yield

10.3%

EHC Fundamentals

EHC Revenue

Revenue (TTM)

4.8B

Rev. Growth (Yr)

9.63%

Rev. Growth (Qtr)

3.31%

EHC Earnings

Earnings (TTM)

352.0M

Earnings Growth (Yr)

-2.01%

Earnings Growth (Qtr)

2.7%

Breaking Down EHC Revenue

Last 7 days

3.1%

Last 30 days

7.8%

Last 90 days

16.9%

Trailing 12 Months

29.7%

How does EHC drawdown profile look like?

EHC Financial Health

Current Ratio

1.28

Debt/Equity

1.63

Debt/Cashflow

0.32

EHC Investor Care

Dividend Yield

0.73%

Dividend/Share (TTM)

0.6

Shares Dilution (1Y)

0.41%

Diluted EPS (TTM)

3.47

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	4.4B	4.6B	4.7B	4.8B
2022	4.1B	4.2B	4.3B	4.3B
2021	4.4B	4.3B	4.2B	4.0B
2020	4.7B	4.6B	4.6B	4.6B
2019	4.4B	4.4B	4.5B	4.6B
2018	4.0B	4.1B	4.2B	4.3B
2017	3.8B	3.8B	3.9B	3.9B
2016	3.3B	3.5B	3.6B	3.7B
2015	2.6B	2.7B	2.9B	3.2B
2014	2.3B	2.3B	2.4B	2.4B
2013	2.2B	2.2B	2.3B	2.3B
2012	2.1B	2.1B	2.1B	2.2B
2011	1.9B	2.0B	2.0B	2.0B
2010	1.8B	1.8B	1.7B	1.9B
2009	0	1.8B	1.8B	1.8B
2008	0	0	0	1.8B

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Encompass Health Corp

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 16, 2024	reidy christopher r	acquired	32,699	79.56	411	-
Apr 16, 2024	christie edward m iii	acquired	25,010	79.65	314	-
Apr 16, 2024	chidsey john	acquired	18,607	79.52	234	-
Apr 15, 2024	reidy christopher r	acquired	-	-	13.00	-
Apr 15, 2024	herman joan e	acquired	-	-	80.00	-
Apr 15, 2024	christie edward m iii	acquired	-	-	2.00	-
Apr 15, 2024	correll donald l	acquired	-	-	184	-
Apr 15, 2024	williams terrance	acquired	-	-	21.00	-
Apr 15, 2024	chidsey john	acquired	-	-	176	-
Apr 15, 2024	o'connor kevin j.	acquired	-	-	11.00	-

Which funds bought or sold EHC recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 23, 2024	NEW MEXICO EDUCATIONAL RETIREMENT BOARD	unchanged	-	324,000	1,684,000	0.06%
Apr 23, 2024	RICE HALL JAMES & ASSOCIATES, LLC	added	15.09	1,356,110	4,551,070	0.26%
Apr 23, 2024	AMALGAMATED BANK	reduced	-0.63	1,002,000	5,359,000	0.05%
Apr 23, 2024	WEDGE CAPITAL MANAGEMENT L L P/NC	reduced	-14.07	826,729	13,831,300	0.22%
Apr 23, 2024	Louisiana State Employees Retirement System	added	2.48	505,058	2,386,560	0.05%
Apr 23, 2024	Global Retirement Partners, LLC	reduced	-15.15	-140	6,916	-%
Apr 23, 2024	REGIONS FINANCIAL CORP	reduced	-1.98	48,801	277,717	-%
Apr 23, 2024	FIFTH THIRD BANCORP	added	3.14	30,000	138,487	-%
Apr 22, 2024	Raymond James Financial Services Advisors, Inc.	reduced	-21.88	-179,294	5,233,670	0.01%
Apr 22, 2024	MetLife Investment Management, LLC	reduced	-1.6	-87,099	3,787,290	0.03%

Are Funds Buying or Selling EHC?

Are funds buying EHC calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own EHC

No. of Funds

Unveiling Encompass Health Corp's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 12, 2024	william blair investment management, llc	5.2%	5,218,171	SC 13G
Feb 12, 2024	vanguard group inc	10.10%	10,120,689	SC 13G/A
Feb 12, 2024	vanguard group inc	9.97%	9,997,034	SC 13G/A
Feb 08, 2024	wellington management group llp	8.20%	8,215,770	SC 13G/A
Jan 24, 2024	blackrock inc.	9.1%	9,125,779	SC 13G/A
Feb 09, 2023	vanguard group inc	9.77%	9,749,441	SC 13G/A
Feb 06, 2023	wellington management group llp	9.58%	9,558,849	SC 13G/A
Jan 30, 2023	blackrock inc.	11.3%	11,232,620	SC 13G/A
Jan 30, 2023	blackrock inc.	11.3%	11,232,620	SC 13G/A
Feb 10, 2022	vanguard group inc	9.46%	9,414,569	SC 13G/A

Recent SEC filings of Encompass Health Corp

View All Filings

Date Filed	Form Type	Document
Apr 16, 2024	4	Insider Trading
Apr 16, 2024	4	Insider Trading
Apr 16, 2024	4	Insider Trading
Apr 16, 2024	4	Insider Trading
Apr 16, 2024	4	Insider Trading
Apr 16, 2024	4	Insider Trading
Apr 16, 2024	4	Insider Trading
Apr 16, 2024	4	Insider Trading
Apr 16, 2024	4	Insider Trading
Apr 16, 2024	4	Insider Trading

Peers (Alternatives to Encompass Health Corp)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	449.3B	371.6B	-0.74%	-0.51%	20.08	1.21	14.64%	11.24%
CI	103.0B	195.3B	0.26%	37.72%	19.17	0.53	8.17%	-20.79%
CVS	86.2B	357.8B	-12.72%	-6.73%	10.32	0.24	10.95%	93.52%
HCA	84.5B	65.0B	-3.19%	11.59%	16.12	1.3	7.86%	-7.11%
CNC	40.8B	154.0B	-1.43%	12.08%	15.09	0.26	6.54%	124.79%
DVA	11.7B	12.1B	-0.12%	51.97%	16.99	0.97	4.57%	23.40%
UHS	11.4B	14.3B	-8.62%	17.22%	15.93	0.8	6.59%	6.24%
MID-CAP
CHE	9.3B	2.3B	-4.84%	8.83%	34.2	4.12	6.06%	9.17%
ACHC	6.5B	2.9B	-7.52%	-4.24%	-301.31	2.23	12.20%	-107.93%
AMN	2.2B	3.8B	-10.62%	-35.16%	10.28	0.57	-27.73%	-52.50%
AMEH	2.1B	1.4B	-5.65%	-0.29%	34.21	1.5	21.19%	34.42%
SMALL-CAP
ADUS	1.5B	1.1B	-8.44%	-16.43%	24.6	1.45	11.31%	35.83%
BKD	1.3B	3.0B	7.61%	59.68%	-6.94	0.44	6.74%	20.73%
BEAT	53.7M	-	-3.27%	-3.72%	-3.67	-	-	-12.94%
AMS	19.0M	21.3M	13.26%	5.28%	35.63	0.89	8.00%	-62.25%

Encompass Health Corp News

Latest updates

Encompass Health Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	3.3%	1,247	1,207	1,187	1,160	1,137	1,090	1,063	1,059	1,043	1,011	1,002	960	1,214	1,174	1,074	1,182	1,184	1,162	1,135	1,124	1,096
Costs and Expenses	2.9%	1,057	1,028	1,003	982	958	941	913	907	656	844	1,069	1,023	61.00	1,001	975	1,002	1,022	990	965	937	985
S&GA Expenses	6.6%	53.00	50.00	55.00	43.00	43.00	38.00	36.00	37.00	42.00	39.00	54.00	39.00	34.00	39.00	43.00	36.00	64.00	53.00	77.00	53.00	54.00
EBITDA Margin	-0.5%	0.21*	0.21*	0.21*	0.20*	0.20*	0.18*	0.19*	0.21*	0.23*	0.21*	0.21*	0.18*	-	-	-	-	-	-	-	-	-
Interest Expenses	-2.8%	35.00	36.00	36.00	36.00	38.00	38.00	60.00	40.00	40.00	40.00	42.00	43.00	46.00	49.00	46.00	43.00	45.00	40.00	38.00	37.00	37.00
Income Taxes	22.8%	37.00	30.00	33.00	32.00	32.00	22.00	23.00	24.00	23.00	26.00	28.00	25.00	38.00	27.00	12.00	27.00	27.00	34.00	24.00	31.00	29.00
Earnings Before Taxes	13.7%	165	145	151	146	151	107	83.00	110	71.00	128	182	167	30.00	127	60.00	136	118	154	135	157	76.00
EBT Margin	0.0%	0.13*	0.13*	0.12*	0.11*	0.10*	0.09*	0.09*	0.12*	0.14*	0.12*	0.12*	0.09*	-	-	-	-	-	-	-	-	-
Net Income	2.7%	88.00	85.00	91.00	88.00	89.00	45.00	49.00	88.00	92.00	100	113	107	86.00	78.00	34.00	87.00	68.00	98.00	91.00	102	28.00
Net Income Margin	-2.8%	0.07*	0.08*	0.07*	0.06*	0.06*	0.06*	0.08*	0.10*	0.10*	0.10*	0.09*	0.07*	-	-	-	-	-	-	-	-	-
Free Cashflow	193.4%	201	69.00	90.00	131	-17.70	-79.20	132	106	-68.50	58.00	142	60.00	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	2.3%	6,102	5,964	5,861	5,747	5,637	5,476	7,082	6,944	6,865	6,722	6,613	6,542	6,446	6,611	6,503	6,138	6,081	6,387	5,812	5,584	5,175
Current Assets	3.5%	842	814	824	762	717	734	1,032	950	921	910	859	1,001	949	1,174	1,102	785	756	1,077	845	683	662
Cash Equivalents	-30.7%	69.00	100	118	85.00	22.00	60.00	136	77.00	49.00	66.00	73.00	224	186	450	419	105	60.00	422	222	56.00	69.00
Net PPE	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,095	2,041	2,003	1,959	1,875	1,788	1,736	1,635
Goodwill	0%	1,281	1,281	1,271	8.00	1,263	1,247	2,457	2,457	1,237	2,418	2,412	2,319	1,228	2,319	2,319	2,312	1,219	2,305	2,112	2,112	2,101
Liabilities	0.8%	3,805	3,775	3,804	3,784	3,775	3,728	4,538	4,452	4,466	4,428	4,404	4,468	4,444	4,681	4,638	4,307	4,148	4,506	3,876	3,694	3,356
Current Liabilities	2.7%	656	639	655	592	576	605	835	755	749	794	805	812	717	683	664	586	721	1,109	753	768	673
Long Term Debt	-0.2%	2,688	2,693	2,698	2,723	2,742	2,719	3,234	3,221	3,241	3,142	3,106	3,160	3,251	3,539	3,547	3,322	3,023	2,962	2,720	2,522	2,479
Shareholder's Equity	5.6%	1,648	1,560	2,018	1,926	1,310	1,710	2,501	2,448	2,357	2,261	2,176	2,043	1,970	1,896	1,831	1,797	1,693	1,671	1,584	1,617	1,557
Retained Earnings	-	407	-	-	-	116	-	-	-	142	-	-	-	-242	-	-	-	-526	-	-	-	-885
Additional Paid-In Capital	-	1,787	-	-	-	1,730	-	-	-	2,290	-	-	-	2,327	-	-	-	2,370	-	-	-	2,589
Shares Outstanding	0%	100	100	100	99.00	99.00	99.00	99.00	99.00	99.00	99.00	99.00	124	-	-	-	-	-	-	-	-	-
Minority Interest	3.5%	608	587	542	542	516	493	498	475	446	418	414	388	382	375	369	353	341	338	308	302	280
Float	-	-	-	6,700	-	-	-	5,500	-	-	-	7,600	-	-	-	6,000	-	-	-	6,200	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	-6.6%	201,000	215,200	206,700	227,900	172,200	70,100	244,600	218,900	123,800	177,600	255,900	158,500	279,700	173,400	222,300	29,300	215,600	114,400	145,400	159,900	178,400
Share Based Compensation	-2.2%	13,400	13,700	15,600	7,900	8,100	7,300	7,700	6,100	9,500	4,800	12,000	2,800	300	8,300	9,900	7,100	27,400	21,700	45,900	19,400	20,300
Cashflow From Investing	-28.3%	-208,100	-162,200	-128,500	-104,000	-206,400	-174,300	-123,200	-123,100	-220,700	-124,000	-226,000	-95,600	-142,700	-89,700	-92,100	-83,000	-145,700	-320,100	-100,100	-91,500	-98,200
Cashflow From Financing	54.6%	-29,900	-65,800	-43,500	-58,000	-16,500	-49,000	-19,300	-60,900	42,300	-18,500	-186,400	-77,500	-354,200	-45,600	182,800	71,100	-424,100	431,800	122,200	-81,700	-67,700
Dividend Payments	-0.7%	14,900	15,000	14,900	15,600	14,900	27,800	27,800	28,500	27,700	27,600	27,800	29,100	27,500	27,600	27,700	29,000	27,400	26,400	26,600	28,300	26,400
Buy Backs	-	-	-	-	-	-	-	-	-	-	-	-	-	1,200	-	-	-	-	2,100	-	-	-

EHC Income Statement

2023-12-31

Consolidated Statements of Comprehensive Income - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Statement [Abstract]
Net operating revenues	$ 4,801.2	$ 4,348.6	$ 4,014.9
Operating expenses:
Salaries and benefits	2,600.1	2,393.3	2,127.3
Other operating expenses	719.1	670.4	595.9
Occupancy costs	56.3	54.7	59.0
Supplies	218.3	202.1	184.2
General and administrative expenses	201.7	154.3	169.5
Depreciation and amortization	273.9	243.6	219.6
Total operating expenses	4,069.4	3,718.4	3,355.5
Loss on early extinguishment of debt	0.0	1.4	1.0
Interest expense and amortization of debt discounts and fees	143.5	175.7	164.3
Other (income) expense	(15.7)	5.2	(7.5)
Equity in net income of nonconsolidated affiliates	(3.2)	(2.9)	(3.4)
Income from continuing operations before income tax expense	607.2	450.8	505.0
Provision for income tax expense	132.2	100.1	101.9
Income from continuing operations	475.0	350.7	403.1
(Loss) income from discontinued operations, net of tax	(12.0)	15.2	114.1
Net and comprehensive income	463.0	365.9	517.2
Net and comprehensive income	463.0	365.9	517.2
Less: Net income attributable to noncontrolling interests included in continuing operations	(111.0)	(93.6)	(103.2)
Less: Net income attributable to noncontrolling interests included in discontinued operations	0.0	(1.3)	(1.8)
Less: Net and comprehensive income attributable to noncontrolling interests	(111.0)	(94.9)	(105.0)
Less: Net and comprehensive income attributable to noncontrolling interests	(111.0)	(94.9)	(105.0)
Net income attributable to Encompass Health	352.0	271.0	412.2
Comprehensive income attributable to Encompass Health	$ 352.0	$ 271.0	$ 412.2
Weighted average common shares outstanding:
Basic (in shares)	99.5	99.2	99.0
Diluted (in shares)	101.3	100.4	100.2
Basic earnings per share attributable to Encompass Health common shareholders:
Continuing operations (in dollars per share)	$ 3.63	$ 2.58	$ 3.02
Discontinued operations (in dollars per share)	(0.12)	0.14	1.13
Net income (in dollars per share)	3.51	2.72	4.15
Diluted earnings per share attributable to Encompass Health common shareholders:
Continuing operations (in dollars per share)	3.59	2.56	2.99
Discontinued operations (in dollars per share)	(0.12)	0.14	1.12
Net income (in dollars per share)	$ 3.47	$ 2.70	$ 4.11
Amounts attributable to Encompass Health:
Income from continuing operations	$ 364.0	$ 257.1	$ 299.9
(Loss) income from discontinued operations, net of tax	(12.0)	13.9	112.3
Net income attributable to Encompass Health	$ 352.0	$ 271.0	$ 412.2

EHC Balance Sheet

2023-12-31

Consolidated Balance Sheets - USD ($)
$ in Millions

Dec. 31, 2023

Dec. 31, 2022

Current assets:

Cash and cash equivalents

$ 69.1

$ 21.8

Restricted cash

35.1

31.6

Accounts receivable

611.6

536.8

Prepaid expenses

34.5

34.9

Other current assets

91.5

92.1

Total current assets

841.8

717.2

Property and equipment, net

3,301.0

2,939.2

Operating lease right-of-use assets

208.5

212.5

Goodwill

1,281.3

1,263.2

Intangible assets, net

278.2

282.3

Other long-term assets

191.6

222.1

Total assets

^[1]

6,102.4

5,636.5

Current liabilities:

Current portion of long-term debt

24.8

25.2

Current operating lease liabilities

24.1

25.6

Accounts payable

170.0

132.9

Accrued payroll

207.5

168.3

Accrued interest payable

42.6

42.8

Other current liabilities

187.4

181.1

Total current liabilities

656.4

575.9

Long-term debt, net of current portion

2,687.8

2,741.8

Long-term operating lease liabilities

196.1

199.7

Self-insured risks

131.8

128.5

Deferred income tax liabilities

87.0

83.0

Other long-term liabilities

46.1

45.7

Total liabilities

^[1]

3,805.2

3,774.6

Commitments and contingencies

Redeemable noncontrolling interests

42.0

35.6

Encompass Health shareholders’ equity:

Common stock, $.01 par value; 200,000,000 shares authorized; issued: 115,416,676 in 2023; 114,775,056 in 2022

1.2

1.1

Capital in excess of par value

1,787.0

1,730.2

Accumulated income

406.5

115.7

Treasury stock, at cost (15,163,909 shares in 2023 and 14,992,125 shares in 2022)

(547.2)

(536.7)

Total Encompass Health shareholders’ equity

1,647.5

1,310.3

Noncontrolling interests

607.7

516.0

Total shareholders’ equity

2,255.2

1,826.3

Liabilities and Equity, Total

^[1]

$ 6,102.4

$ 5,636.5

[1]

Our consolidated assets as of December 31, 2023 and December 31, 2022 include total assets of variable interest entities of $207.7 million and $207.8 million, respectively, which cannot be used by us to settle the obligations of other entities. Our consolidated liabilities as of December 31, 2023 and December 31, 2022 include total liabilities of the variable interest entities of $42.2 million and $47.9 million, respectively. See Note 4, Variable Interest Entities.

About Encompass Health Corp

Encompass Health Corporation provides post-acute healthcare services in the United States. It provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides services under the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.

CEO	Mr. Mark J. Tarr
WEBSITE	encompasshealth.com
INDUSTRY	Healthcare Plans
EMPLOYEES	36900

Encompass Health Corp Frequently Asked Questions

What is the ticker symbol for Encompass Health Corp? What does EHC stand for in stocks?

EHC is the stock ticker symbol of Encompass Health Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Encompass Health Corp (EHC)?

As of Tue Apr 23 2024, market cap of Encompass Health Corp is 8.26 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of EHC stock?

You can check EHC's fair value in chart for subscribers.

What is the fair value of EHC stock?

You can check EHC's fair value in chart for subscribers. The fair value of Encompass Health Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Encompass Health Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for EHC so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Encompass Health Corp a good stock to buy?

The fair value guage provides a quick view whether EHC is over valued or under valued. Whether Encompass Health Corp is cheap or expensive depends on the assumptions which impact Encompass Health Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for EHC.

What is Encompass Health Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 23 2024, EHC's PE ratio (Price to Earnings) is 23.46 and Price to Sales (PS) ratio is 1.72. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. EHC PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Encompass Health Corp's stock?

In the past 10 years, Encompass Health Corp has provided 0.135 (multiply by 100 for percentage) rate of return.